TMCnet News

Plexus Announces Modest North American Expansions
[April 07, 2008]

Plexus Announces Modest North American Expansions


NEENAH, Wis., April 7, 2008 /PRNewswire-FirstCall/ -- Plexus Corp. today announced that it has committed to two facility leases that will modestly expand its North American manufacturing footprint. Plexus' San Jose-area operation will relocate to a larger 46,000 sq ft facility located approximately eight miles from the existing facility. Plexus' Chicago-area operation will expand into a 48,000 sq ft facility adjacent to the existing facility, bringing the site's total footprint to 189,000 sq ft.



"Our facilities in North America are integral components of Plexus' global manufacturing and supply chain solution set, supporting our focus on mid-to-low-volume, mid-to-high-mix customer programs that require flexibility, agility and flawless execution," stated Mike Buseman, Sr. VP - Global Manufacturing Operations. "We believe that these strategic facility investments are vitally important to delivering a lowest total cost value proposition to our customers."

Plexus' San Jose-area facility will relocate from the existing 36,000 sq ft site to a larger facility with 46,000 sq ft. The newer and larger facility will accommodate better operational flow, an improved work environment and investments in manufacturing technology to better serve our customers in this geographically important market. Plexus' San Jose-area facility supports customers in all four of Plexus' sectors with significant expertise in the Wireline/Networking and Wireless Infrastructure sector. The site also serves as a new product introduction and production ramp facility for strategic growth customers.


Plexus' Chicago-area facility has seen increased demand from customers, particularly in the Medical sector. The additional 48,000 sq ft coupled with the current 141,000 sq ft will position the facility to support current customer demands and further growth in revenue for after market services, Configure to Order (CTO) and distribution services for North American end-customers. Plexus' Chicago-area facility is approved by the Food and Drug Administration (FDA) to manufacture finished class II and III medical devices.

About Plexus Corp. - The Product Realization Company
Plexus (http://www.plexus.com/) is an award-winning participant in the Electronics Manufacturing Services (EMS) industry, providing product design, supply chain and materials management, manufacturing, test, fulfillment and aftermarket solutions to branded product companies in the Wireline/Networking, Wireless Infrastructure, Medical, Industrial/Commercial and Defense/Security/Aerospace market sectors.

The Company's unique Focused Factory manufacturing model and global supply chain solutions are strategically enhanced by value-added product design and engineering services. Plexus specializes in mid- to low-volume, higher-mix customer programs that require flexibility, scalability, technology and quality.

Plexus provides award-winning customer service to more than 100 branded product companies in North America, Europe and Asia.

Safe Harbor and Fair Disclosure Statement
The statements contained in this release which are guidance or which are not historical facts (such as statements in the future tense and statements including "believe," "expect," "intend," "plan," "anticipate," "goal," "target" and similar terms and concepts), including all discussions of periods which are not yet completed, are forward-looking statements that involve risks and uncertainties. Plexus' future performance is subject to many other factors, including, but not limited to: the economic performance of the electronics, technology and defense industries; market reaction to previously announced share repurchase programs; the risk of customer delays, changes or cancellations in both ongoing and new programs; the poor visibility of future orders in the defense market sector and the uncertainty of defense appropriations and spending; the effects of the volume of revenue from certain sectors or programs on our margins in particular periods; the Company's ability to secure new customers and maintain its current customer base; the risks of concentration of work for certain customers; material cost fluctuations and the adequate availability of components and related parts for production; the effect of changes in average selling prices; the effect of start-up costs of new programs and facilities, including our expansions in Asia; the adequacy of restructuring and similar charges as compared to actual expenses; the degree of success and the costs of efforts to improve the financial performance of its Mexican operations; possible unexpected costs and operating disruption in transitioning programs; the costs and inherent uncertainties of pending litigation; the effect of general economic conditions and world events (such as increases in oil prices, terrorism and war in the Middle East); the impact of increased competition; and other risks detailed in the Company's Securities and Exchange Commission filings -- in particular in "Risk Factors" in Part II, Item 1A of the Company's Quarterly Report on Form 10-Q for the quarter ended December 29, 2007.

Plexus Corp.

CONTACT: Ginger Jones, Vice President, Chief Financial Officer of PlexusCorp., +1-920-751-5487, [email protected]

Web site: http://www.plexus.com/

[ Back To TMCnet.com's Homepage ]